Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any mosaic variegated aneuploidy syndrome in which the cause of the disease is a mutation in the BUB1B gene.
Features include always present findings: Microcephaly, Small for gestational age, and Intrauterine growth retardation; and sometimes findings: Seizure, Cerebral hypoplasia, Pulmonic stenosis, and Embryonal rhabdomyosarcoma and others. 57 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 9 | Bilateral tonic-clonic seizure, Seizure, Profound intellectual disability |
BUB1B encodes BUB1 mitotic checkpoint serine/threonine kinase B (1,050 aa). Essential component of the mitotic checkpoint. Required for normal mitosis progression. The mitotic checkpoint delays anaphase until all chromosomes are properly attached to the mitotic spindle. Highest expression in Cells EBV-transformed lymphocytes (71.1 TPM) and Testis (46.8 TPM).
Mosaic variegated aneuploidy syndrome 1 is caused by mutations in the BUB1B gene on chromosome 15.
BUB1B is classified as a druggable target (Clinically Actionable, Druggable Genome, Enzyme, Kinase, and Serine Threonine Kinase categories) with score 8.7.
Genetic testing for BUB1B is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 3 always present features.
No clinical trials have been registered for mosaic variegated aneuploidy syndrome 1.
5 publications have been identified in PubMed for mosaic variegated aneuploidy syndrome 1. Research spans Review / Meta-Analysis (40%), Basic Science / Preclinical (40%), and Case Report / Case Series (20%).
Pun R (2025). [PMID: 40055864](https://pubmed.ncbi.nlm.nih.gov/40055864/). *J Am Heart Assoc*. [Basic Science / Preclinical]
Qu J (2025). [PMID: 40555658](https://pubmed.ncbi.nlm.nih.gov/40555658/). *Zhonghua Yi Xue Yi Chuan Xue Za Zhi*. [Review / Meta-Analysis]
Cheng P (2025). [PMID: 40333415](https://pubmed.ncbi.nlm.nih.gov/40333415/). *Annu Rev Genomics Hum Genet*. [Review / Meta-Analysis]
Silva MP (2024). [PMID: 39014450](https://pubmed.ncbi.nlm.nih.gov/39014450/). *J Biomed Sci*. [Basic Science / Preclinical]
Esposito M (2024). [PMID: 38664248](https://pubmed.ncbi.nlm.nih.gov/38664248/). *Int J Legal Med*. [Case Report / Case Series]
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 6:58 PM UTC
Online Mendelian Inheritance in Man
Growth and development |
3 |
Short stature, Postnatal growth retardation, Intrauterine growth retardation |
Kidneys and urinary system | 3 | Nephroblastoma, Multicystic kidney dysplasia, Renal cyst |
Eyes | 2 | Cataract, Nystagmus |
Head and neck | 2 | Cleft palate, Microcephaly |
Muscles | 1 | Generalized hypotonia |
Blood and immune system | 1 | Combined immunodeficiency |
Digestive system | 1 | Feeding difficulties in infancy |
Heart and blood vessels | 1 | Atrial septal defect |